$1.51
0.117.86%
Ult. Agg.: Nov 6, 4:20 PM
The average analyst price target for Elicio Therapeutics is $14.83, 902.0% above the current price. Of 5 analysts, 4 rate it Buy and 1 Hold. Targets range from $8 to $23. The latest change came on Sep 24, 2026, when B. Riley Securities lowered its price target on Elicio Therapeutics from $27 to $8 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months